Richard Jeremy Franklin

This inventor holds 11 USPTO granted patents, plus 3 CIPO patents and 7 EPO patents. Top assignees: Ucb Pharma, S.a., Ucbbiopharma Srl, Celltech R&d Limited. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Jeremy Franklin. Retrieved from https://idiyas.com/inventor/richard-jeremy-franklin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 11

% Patents Active = 63.6

CIPO Patents = 3 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 6)

Average Co-Inventor Count = 7.2

ph-index = 3

Forward Citations = 29(Granted Patents)

Location History:

Slough, GB (2008 - 2021)
Berkshire, GB (2024)

Company Filing History:

Katholieke Universiteit Leuven

6. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617786 - Dihydro-cyclopenta-isoquinoline sulfonamides derivatives (2026-05-05),

2. 12018021 - Thiophene derivatives for the treatment of disorders caused by IgE (2024-06-25),

3. RE48622 - Therapeutically active pyrazolo-pyrimidine derivatives (2021-07-05),

4. 9714248 - Therapeutically active pyrazolo-pyrimidine derivatives (2017-07-25),

5. 9382263 - Therapeutically active oxazoline derivatives (2016-07-05),

6. 9096614 - Therapeutically active thiazolo-pyrimidine derivatives (2015-08-04),

7. 9029392 - Quinoline derivatives as kinase inhibitors (2015-05-12),

8. 8710054 - Fused thiazole derivatives as kinase inhibitors (2014-04-29),

9. 8338592 - Fused thiazole derivatives as kinase inhibitors (2012-12-25),

10. 8242116 - Fused thiazole derivatives as kinase inhibitors (2012-08-14),

11. 7323464 - Pyridine and pyrimidine derivatives (2008-01-29),

Title: Richard Jeremy Franklin: Innovator in Pharmaceutical Patents

Introduction

Richard Jeremy Franklin is a notable inventor based in Slough, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work primarily focuses on developing innovative compounds for the treatment of various medical conditions.

Latest Patents

Franklin's latest patents include "Thiophene derivatives for the treatment of disorders caused by IgE." This patent presents thiophene derivatives that are effective in treating or preventing disorders caused by IgE, such as allergies and type 1 hypersensitivity. Another significant patent is for "Therapeutically active pyrazolo-pyrimidine derivatives." This series of compounds is beneficial in treating a range of human ailments, including inflammatory, autoimmune, and oncological disorders, as well as viral diseases and organ transplant rejection.

Career Highlights

Throughout his career, Franklin has worked with prominent companies, including UCB Pharma. His innovative research has led to advancements in pharmaceutical treatments, showcasing his dedication to improving healthcare outcomes.

Collaborations

Franklin has collaborated with notable colleagues, including Daniel James Ford and Daniel Christopher Brookings. These partnerships have contributed to the success of his research and patent developments.

Conclusion

Richard Jeremy Franklin's contributions to pharmaceutical innovations highlight his role as a key inventor in the industry. His patents reflect a commitment to addressing significant health challenges through scientific advancements.

Profile summary based on public USPTO records.